Literature DB >> 14968940

Proton beams to replace photon beams in radical dose treatments.

Herman Suit1, Saveli Goldberg, Andrzej Niemierko, Alexei Trofimov, Judith Adams, Harald Paganetti, George T Y Chen, Thomas Bortfeld, Stanley Rosenthal, Jay Loeffler, Thomas Delaney.   

Abstract

With proton beam radiation therapy a smaller volume of normal tissues is irradiated at high dose levels for most anatomic sites than is feasible with any photon technique. This is due to the Laws of Physics, which determine the absorption of energy from photons and protons. In other words, the dose from a photon beam decreases exponentially with depth in the irradiated material. In contrast, protons have a finite range and that range is energy dependent. Accordingly, by appropriate distribution of proton energies, the dose can be uniform across the target and essentially zero deep to the target and the atomic composition of the irradiated material. The dose proximal to the target is lower compared with that in photon techniques, for all except superficial targets This resultant closer approximation of the planning treatment volume (PTV) to the CTV/GTV (grossly evident tumor volume/subclinical tumor extensions) constitutes a clinical gain by definition; i.e. a smaller treatment volume that covers the target three dimensionally for the entirety of each treatment session provides a clinical advantage. Several illustrative clinical dose distributions are presented and the clinical outcome results are reviewed briefly. An important technical advance will be the use of intensity modulated proton radiation therapy, which achieves contouring of the proximal edge of the SOBP (spread out Bragg peak) as well as the distal edge. This technique uses pencil beam scanning. To permit further progressive reductions of the PTV, 4-D treatment planning and delivery is required. The fourth dimension is time, as the position and contours of the tumor and the adjacent critical normal tissues are not constant. A potentially valuable new method for assessing the clinical merits of each of a large number of treatment plans is the evaluation of multidimensional plots of the complication probabilities for each of 'n' critical normal tissues/ structures for a specified tumor control probability. The cost of proton therapy compared with that of very high technology photon therapy is estimated and evaluated. The differential is estimated to be approximately 1.5 provided there were to be no charge for the original facility and that there were sufficient patients for operating on an extended schedule (6-7 days of 14-16 h) with > or = two gantries and one fixed horizontal beam.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14968940     DOI: 10.1080/02841860310017676

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  25 in total

1.  Segmental analysis of respiratory liver motion in patients with and without a history of abdominal surgery.

Authors:  Yasuhiro Shimizu; Shigeyuki Takamatsu; Kazutaka Yamamoto; Yoshikazu Maeda; Makoto Sasaki; Hiroyasu Tamamura; Sayuri Bou; Tomoyasu Kumano; Toshifumi Gabata
Journal:  Jpn J Radiol       Date:  2018-06-20       Impact factor: 2.374

2.  Cancer treatment: Sharp shooters.

Authors:  Vivien Marx
Journal:  Nature       Date:  2014-04-03       Impact factor: 49.962

3.  Proton beam stereotactic radiosurgery for pediatric cerebral arteriovenous malformations.

Authors:  Brian P Walcott; Jona A Hattangadi-Gluth; Christopher J Stapleton; Christopher S Ogilvy; Paul H Chapman; Jay S Loeffler
Journal:  Neurosurgery       Date:  2014-04       Impact factor: 4.654

4.  Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.

Authors:  Zhongxing Liao; J Jack Lee; Ritsuko Komaki; Daniel R Gomez; Michael S O'Reilly; Frank V Fossella; George R Blumenschein; John V Heymach; Ara A Vaporciyan; Stephen G Swisher; Pamela K Allen; Noah Chan Choi; Thomas F DeLaney; Stephen M Hahn; James D Cox; Charles S Lu; Radhe Mohan
Journal:  J Clin Oncol       Date:  2018-01-02       Impact factor: 44.544

Review 5.  Esophagitis, treatment-related toxicity in non-small cell lung cancer.

Authors:  Voichita Bar-Ad; Nitin Ohri; Maria Werner-Wasik
Journal:  Rev Recent Clin Trials       Date:  2012-02

6.  Predicted rates of secondary malignancies from proton versus photon radiation therapy for stage I seminoma.

Authors:  Charles B Simone; Kevin Kramer; William P O'Meara; Justin E Bekelman; Arnaud Belard; James McDonough; John O'Connell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-01-13       Impact factor: 7.038

Review 7.  Advanced-stage pancreatic cancer: therapy options.

Authors:  Jens Werner; Stephanie E Combs; Christoph Springfeld; Werner Hartwig; Thilo Hackert; Markus W Büchler
Journal:  Nat Rev Clin Oncol       Date:  2013-04-30       Impact factor: 66.675

Review 8.  Gastrointestinal radiation injury: prevention and treatment.

Authors:  Abobakr K Shadad; Frank J Sullivan; Joseph D Martin; Laurence J Egan
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

9.  Cancer radiotherapy based on femtosecond IR laser-beam filamentation yielding ultra-high dose rates and zero entrance dose.

Authors:  Ridthee Meesat; Hakim Belmouaddine; Jean-François Allard; Catherine Tanguay-Renaud; Rosalie Lemay; Tiberius Brastaviceanu; Luc Tremblay; Benoit Paquette; J Richard Wagner; Jean-Paul Jay-Gerin; Martin Lepage; Michael A Huels; Daniel Houde
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-27       Impact factor: 11.205

Review 10.  National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury.

Authors:  Daphne Haas-Kogan; Daniel Indelicato; Harald Paganetti; Natia Esiashvili; Anita Mahajan; Torunn Yock; Stella Flampouri; Shannon MacDonald; Maryam Fouladi; Kry Stephen; John Kalapurakal; Stephanie Terezakis; Hanne Kooy; David Grosshans; Mike Makrigiorgos; Kavita Mishra; Tina Young Poussaint; Kenneth Cohen; Thomas Fitzgerald; Vinai Gondi; Arthur Liu; Jeff Michalski; Dragan Mirkovic; Radhe Mohan; Stephanie Perkins; Kenneth Wong; Bhadrasain Vikram; Jeff Buchsbaum; Larry Kun
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-05-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.